Logo image
Sign in
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia
Journal article   Peer reviewed

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Rémi Letestu, Abdelmalek Dahmani, Marouane Boubaya, Lucile Baseggio, Lydia Campos, Bernard Chatelain, Agathe Debliquis, Bernard Drénou, Marie-Christine Jacob, Eric Legac, …
Leukemia, Vol.35(6), pp.1597-1609
06/2021
PMID: 32934355

Abstract

Aged Antineoplastic Combined Chemotherapy Protocols Bone Marrow Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Cyclophosphamide Female Follow-Up Studies Humans Immunotherapy Leukemia, Lymphocytic, Chronic, B-Cell Male Neoplasm, Residual Prognosis Retrospective Studies Rituximab Survival Rate Vidarabine
url
Find in HALView

Metrics

1 Record Views

Details

Logo image